BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33580477)

  • 21. Levetiracetam and cutaneous adverse reactions: A systematic review of descriptive studies.
    Rashid M; Rajan AK; Chhabra M; Kashyap A
    Seizure; 2020 Feb; 75():101-109. PubMed ID: 31931437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous Adverse Drug Reactions (CADRs)-Statistical Analysis of the Causal Relationship between the Drug, Comorbidities, Cofactors, and the Cutaneous Reaction-A Single-Centered Study.
    Machoń N; Lewandowska J; Zdanowska N; Placek W; Owczarczyk-Saczonek A
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The extent of cytochrome P450 3A induction by antiseizure medications: A systematic review and network meta-analysis.
    Cohen H; Mahajna G; Ben-Shushan T; Matok I; Eyal S
    Epilepsia; 2024 Feb; 65(2):445-455. PubMed ID: 38010146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of Antiseizure Medication-Induced Severe Cutaneous Adverse Reactions in Malaysia.
    Fong SL; Lim KS; Hariraj V; Lee SC; Wo WK; Ramli A; Ho JH; Lai PSM; Ng WL
    J Clin Pharmacol; 2022 Aug; 62(8):983-991. PubMed ID: 35230712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Movement disorders associated with antiseizure medications: A real-world disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System.
    Zhou J; Wei Z; Chen S; Xie H; Huang W; Liu M; Wu X
    Br J Clin Pharmacol; 2023 Nov; 89(11):3389-3400. PubMed ID: 37353394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of pregnancy on the pharmacokinetics of antiseizure medications: A systematic review and meta-analysis of data from 674 pregnancies.
    Schoretsanitis G; Deligiannidis KM; Kasperk N; Schmidt CT; Kittel-Schneider S; Ter Horst P; Berlin M; Kohn E; Poels EMP; Zutshi D; Tomson T; Spigset O; Paulzen M
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jul; 133():111030. PubMed ID: 38762161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study.
    Thakkar S; Patel TK; Vahora R; Bhabhor P; Patel R
    Indian J Dermatol; 2017; 62(6):618-625. PubMed ID: 29263536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous adverse drug reactions in Indian population: A systematic review.
    Patel TK; Thakkar SH; Sharma D
    Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse cutaneous drug reactions among hospitalized patients: five year surveillance.
    Turk BG; Gunaydin A; Ertam I; Ozturk G
    Cutan Ocul Toxicol; 2013 Mar; 32(1):41-5. PubMed ID: 22812902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy.
    Alsfouk BAA; Brodie MJ; Walters M; Kwan P; Chen Z
    JAMA Neurol; 2020 May; 77(5):574-581. PubMed ID: 32091535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retention of antiseizure medications for epilepsy in multiple sclerosis: A retrospective observational study.
    Mahamud Z; Håkansson S; Burman J; Zelano J
    Epilepsy Behav; 2021 Aug; 121(Pt A):108034. PubMed ID: 34004524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of
    John S; Balakrishnan K; Sukasem C; Anand TCV; Canyuk B; Pattharachayakul S
    J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008-2017.
    Kim HK; Kim DY; Bae EK; Kim DW
    J Korean Med Sci; 2020 Feb; 35(4):e17. PubMed ID: 31997613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions.
    McCormack M; Urban TJ; Shianna KV; Walley N; Pandolfo M; Depondt C; Chaila E; O'Conner GD; Kasperavičiūtė D; Radtke RA; Heinzen EL; Sisodiya SM; Delanty N; Cavalleri GL
    Pharmacogenomics; 2012 Mar; 13(4):399-405. PubMed ID: 22379998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The HLA-B*15:02 polymorphism and Tegretol
    Chouchi M; Kaabachi W; Tizaoui K; Daghfous R; Aidli SE; Hila L
    Rev Neurol (Paris); 2018 May; 174(5):278-291. PubMed ID: 29685430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and clinical risk factors associated with phenytoin-induced cutaneous adverse drug reactions in Thai population.
    Sukasem C; Sririttha S; Tempark T; Klaewsongkram J; Rerkpattanapipat T; Puangpetch A; Boongird A; Chulavatnatol S
    Pharmacoepidemiol Drug Saf; 2020 May; 29(5):565-574. PubMed ID: 32134161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rash from antiepileptic drugs: influence by gender, age, and learning disability.
    Alvestad S; Lydersen S; Brodtkorb E
    Epilepsia; 2007 Jul; 48(7):1360-5. PubMed ID: 17484761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ciprofloxacin-induced cutaneous adverse drug events: a systematic review of descriptive studies.
    Kashyap A; Sreenivasan S; Rajan AK; Rashid M; Chhabra M
    J Basic Clin Physiol Pharmacol; 2021 Mar; 33(3):327-346. PubMed ID: 33725760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cosmetic adverse effects of antiseizure medications; A systematic review.
    Asadi-Pooya AA; Rostaminejad M; Zeraatpisheh Z; Mirzaei Damabi N
    Seizure; 2021 Oct; 91():9-21. PubMed ID: 34052629
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.